Search Results - "Ghilli, Matteo"
-
1
Molecular Mechanisms, Biomarkers and Emerging Therapies for Chemotherapy Resistant TNBC
Published in International journal of molecular sciences (31-01-2022)“…Triple-negative breast cancer (TNBC) is associated with high recurrence rates, high incidence of distant metastases, and poor overall survival (OS). Taxane and…”
Get full text
Journal Article -
2
Androgen receptor expression inversely correlates with histological grade and N stage in ER+/PgRlow male breast cancer
Published in Breast cancer research and treatment (01-07-2020)“…Purpose Androgen Receptor (AR) positivity is often displayed in breast cancer and especially in Male Breast Cancer (MBC), where it appears to be a…”
Get full text
Journal Article -
3
Doxycycline, an Inhibitor of Mitochondrial Biogenesis, Effectively Reduces Cancer Stem Cells (CSCs) in Early Breast Cancer Patients: A Clinical Pilot Study
Published in Frontiers in oncology (12-10-2018)“…Cancer stem cells (CSCs) have been implicated in tumor initiation, recurrence, metastatic spread and poor survival in multiple tumor types, breast cancers…”
Get full text
Journal Article -
4
The BRCA1 c.4096+1G>A Is a Founder Variant Which Originated in Ancient Times
Published in International journal of molecular sciences (01-11-2023)“…Approximately 30–50% of hereditary breast and ovarian cancer (HBOC) is due to the presence of germline pathogenic variants in the BRCA1 (OMIM 113705) and BRCA2…”
Get full text
Journal Article -
5
Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients
Published in Breast (Edinburgh) (01-12-2021)“…Type of axillary surgery in breast cancer (BC) patients who convert from cN + to ycN0 after neoadjuvant chemotherapy (NAC) is still debated. The aim of the…”
Get full text
Journal Article -
6
Systematic and continuous collection of patient-reported outcomes and experience in women with cancer undergoing mastectomy and immediate breast reconstruction: a study protocol for the Tuscany Region (Italy)
Published in BMJ open (11-01-2021)“…IntroductionMonitoring how patients feel and what they experience during the care process gives health professionals data to improve the quality of care, and…”
Get full text
Journal Article -
7
Management of the axilla in breast cancer patients: critical review, regional modified Delphi consensus and implementation in the Tuscan breast network
Published in Radiologia medica (01-06-2024)“…Purpose Data from recently trials have provided practice-changing recommendations in management of the axilla in early breast cancer (eBC). However, further…”
Get full text
Journal Article -
8
Cell-free biomimetic polyurethane-based scaffold for breast reconstruction following non-malignant lesion resection. A first-in-human study
Published in Breast cancer (Tokyo, Japan) (01-07-2023)“…Background Based on the volume of tissue removed, conservative surgery (BCS) cannot always guarantee satisfactory cosmetic results, unless resorting to more…”
Get full text
Journal Article -
9
Wearable AR and 3D Ultrasound: Towards a Novel Way to Guide Surgical Dissections
Published in IEEE access (2021)“…Nowadays, ultrasound (US) is increasingly being chosen as imaging modality for both diagnostic and interventional applications, owing to its positive…”
Get full text
Journal Article -
10
Detection of Germline Variants in 450 Breast/Ovarian Cancer Families with a Multi-Gene Panel Including Coding and Regulatory Regions
Published in International journal of molecular sciences (19-07-2021)“…With the progress of sequencing technologies, an ever-increasing number of variants of unknown functional and clinical significance (VUS) have been identified…”
Get full text
Journal Article -
11
Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis
Published in Therapeutic advances in medical oncology (01-01-2023)“…Background: Systemic inflammatory markers draw great interest as potential blood-based prognostic factors in several oncological settings. Objectives: The aim…”
Get full text
Journal Article -
12
Catching and monitoring clinical innovation through performance indicators. The case of the breast-conserving surgery indicator
Published in BMC research notes (17-07-2017)“…The evolution in the surgical and diagnostic procedures, the attention to women's preferences, the case mix, and differences in professional practices may lead…”
Get full text
Journal Article -
13
-
14
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients
Published in Breast cancer research and treatment (01-11-2019)“…Purpose Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) improve progression-free survival (PFS) in patients with hormone receptor-positive (HR+) advanced…”
Get full text
Journal Article -
15
Preservation of Axillary Lymph Nodes Compared with Complete Dissection in T1–2 Breast Cancer Patients Presenting One or Two Metastatic Sentinel Lymph Nodes: The SINODAR-ONE Multicenter Randomized Clinical Trial
Published in Annals of surgical oncology (01-09-2022)“…Background The SINODAR-ONE trial is a prospective noninferiority multicenter randomized study aimed at assessing the role of axillary lymph node dissection…”
Get full text
Journal Article -
16
Androgen receptor expression inversely correlates with histological grade and N stage in ER.sup.+/PgR.sup.low male breast cancer
Published in Breast cancer research and treatment (01-07-2020)“…Purpose Androgen Receptor (AR) positivity is often displayed in breast cancer and especially in Male Breast Cancer (MBC), where it appears to be a…”
Get full text
Journal Article -
17
PI3K mutations detected in liquid biopsy are associated to reduced sensitivity to CDK4/6 inhibitors in metastatic breast cancer patients
Published in Pharmacological research (01-01-2021)“…[Display omitted] •Predictive biomarkers of resistance to CDK4/6 inhibitors are not yet available for patients’ selection.•PI3K mutations correlate with a…”
Get full text
Journal Article -
18
The IBRCA1/I c.4096+1GA Is a Founder Variant Which Originated in Ancient Times
Published in International journal of molecular sciences (01-10-2023)“…Approximately 30–50% of hereditary breast and ovarian cancer (HBOC) is due to the presence of germline pathogenic variants in the BRCA1 (OMIM 113705) and BRCA2…”
Get full text
Journal Article -
19
Prospective study on Oncotype DX® assay to assess recurrence risk in early ER-positive HER2-negative breast cancer patients with uncertain biological behavior by standard parameters and its impact on treatment recommendation: The POST trial
Published in European journal of cancer (1990) (01-12-2024)“…Data published in 2015 showed that patients with early breast cancer (EBC) and a low-risk (LR) Recurrence Score® (RS) result by the 21-gene Oncotype DX® assay…”
Get full text
Journal Article -
20